Prestige Consumer Healthcare PBH Cost of sales excluding depreciation
Cost of sales excluding depreciation at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept pbh:CostOfSalesExclusiveOfDepreciation.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's cost of sales excluding depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prestige Consumer Healthcare's cost of sales excluding depreciation?
- Prestige Consumer Healthcare (PBH) reported cost of sales excluding depreciation of $132.4M in Q1 2026.
- How has Prestige Consumer Healthcare's cost of sales excluding depreciation changed year-over-year?
- Prestige Consumer Healthcare's cost of sales excluding depreciation increased by 6.5% year-over-year, from $124.32M to $132.4M.
- What is the long-term trend for Prestige Consumer Healthcare's cost of sales excluding depreciation?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's cost of sales excluding depreciation has grown at a 1.3% compound annual growth rate (CAGR), from $458.94M to $482.79M.
- What does cost of sales excluding depreciation mean?
- Represents the direct costs associated with producing goods or services, excluding non-cash depreciation charges. This metric isolates the variable and fixed cash-based production expenses, providing a clearer view of the underlying manufacturing or procurement efficiency.